| Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to introduce a 4 th cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results. Cannabis Science has received images and documented information from this 4 th patient who has basal cell carcinoma on his left nostril. The patient is enrolled in a photog...continued CBIS |
Thursday, February 2, 2012
Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment